Skip to main content
Premium Trial:

Request an Annual Quote

Definiens, Merck KGaA Partner for Biomarker Discovery

NEW YORK (GenomeWeb) — Definiens said today that it has entered a biomarker alliance with Germany's Merck KGaA.

Under the terms of the multi-year deal, Merck's healthcare business will use Definiens' web-based collaboration software platform — which enables the uploading, accessing, searching, and sharing of data — to support its use of Definiens' Tissue Phenomics image-analysis technologies for biomarker quantification including immuno-profiling.

Additional terms were not disclosed.

"This partnership agreement is a testament to Definiens' ability to transform tissue image data into valuable insights using our proprietary data mining methods for biomarker discovery," Oliver Lehner, vice president of business development and partnering at Definiens, said in a statement.

Last year, Definiens — a subsidiary of AstraZeneca — expanded its cancer biomarker alliance with NeoGenomics to include assay development and automation. In late 2016, Takeda began using Definiens' cloud-based digital pathology platform in its translational and biomarker research.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.